It would seem to me they are more interested in becoming a successful Bio tech company than making money, I’m starting to wonder if they had a buy out offer would they take it? Or just push for a licensing deal and lose both. Profit does not seem to be their motive,either that or they are totally inept.
News 
Market Data 
Discover 
